---
title: "Grace Therapeutics, Inc. (GRCE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GRCE.US.md"
symbol: "GRCE.US"
name: "Grace Therapeutics, Inc."
industry: "Pharmaceuticals"
---

# Grace Therapeutics, Inc. (GRCE.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.gracetx.com](https://www.gracetx.com) |

## Company Profile

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company’s lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -11.10 | 189/257 | - | - | - |
| PB | 1.02 | 46/257 | 0.83 | 0.70 | 0.63 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 67% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 4.29 |
| Highest Target | 12.27 |
| Lowest Target | 10.99 |

## References

- [Company Overview](https://longbridge.com/en/quote/GRCE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GRCE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GRCE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.